At Decade Mark, how are Pharmaceutical Companies Successfully Executing Risk Evaluation and Mitigation Strategies Programs?

CHAPEL HILL, N.C., July 17, 2017 /PRNewswire/ -- It has been 10 years since the U.S. Food and Drug Administration gained the authority to require pharmaceutical companies to develop Risk Evaluation and Mitigation Strategies (REMS) for products that may have safety issues.Given the...